TETRAHYDROBIOPTERIN METABOLISM IN SENILE DEMENTIA OF ALZHEIMER TYPE

TETRAHYDROBIOPTERIN METABOLISM IN SENILE DEMENTIA OF ALZHEIMER TYPE

Show other versions (1)

Bibliographic Details
Main Authors:	Jones, S, Armstrong, R, Blair, J, Leeming, R, Chaudhry, S, Swade, C, Coppen, A
Format:	Journal article
Published:	1987

Similar Items

Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
by: Morar, C, et al.
Published: (1983)

Depression and tetrahydrobiopterin: the folate connection.
by: Coppen, A, et al.
Published: (1989)

Tacrine for senile dementia of Alzheimer's or Lewy body type.
by: Wilcock, G, et al.
Published: (1994)

The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
by: Wilcock, G, et al.
Published: (1988)

Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
by: Appleyard, M, et al.
Published: (1987)

Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
by: Ballard, C, et al.
Published: (1996)

Senile Dementia from Neuroscientific and Islamic Perspectives
by: Tumiran, Mohd Amzari, et al.
Published: (2018)

Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
by: Pearson, R, et al.
Published: (1983)

Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type.
by: Jamieson, G, et al.
Published: (1992)

Galanthamine hydrobromide: Interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer type
by: Wilcock, G, et al.
Published: (1997)

The temporal lobe in dementia of Alzheimer's type.
by: Wilcock, G
Published: (1983)

Neuroimaging, cognitive, and pathological changes in dementia of the Alzheimer type (DAT).
by: Besson, J, et al.
Published: (1989)

Donepezil for dementia due to Alzheimer's disease
by: Birks, J, et al.
Published: (2018)

Correction of tetrahydrobiopterin deficiency - Implications for dopa responsive dystonia and other inherited disorders of tetrahydrobiopterin metabolism
by: Heales, S, et al.
Published: (2005)

Functional dopamine deficits in the senile rat retina.
by: Hankins, M
Published: (2000)

Senile parkinsonism, a study of current treatment.
by: White, N, et al.
Published: (1981)

Dopamine pathways are selectively affected in the senile retina.
by: Hankins, M
Published: (2000)

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
by: Compta, Y, et al.
Published: (2011)

In vivo localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease
by: Jean, L, et al.
Published: (2019)

The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type.
by: Amar, K, et al.
Published: (1996)

The effects of tetrahydrobiopterin and hyperglycaemia on macrophage metabolism in cardiovascular inflammation
by: Ayaz, F
Published: (2023)

Are phosphodiesterase type 5 inhibitors potential therapies for Alzheimer’s Disease and related dementias?
by: Newby, D
Published: (2022)

Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
by: Gustavsson, A, et al.
Published: (2009)

Metal protein attenuating compounds for the treatment of Alzheimer's dementia
by: Sampson, E, et al.
Published: (2012)

Analysis of spontaneous, conversational speech in dementia of Alzheimer type: Evaluation of an objective technique for analysing lexical performance
by: Bucks, R, et al.
Published: (2000)

The differentiation of major depression from dementia of the Alzheimer type using within-subject neuropsychological discrepancy analysis.
by: O'Carroll, R, et al.
Published: (1994)

ELEVATED URINARY NEOPTERIN SUGGESTS IMMUNE ACTIVATION IN ALZHEIMERS-DISEASE AND DOWNS-SYNDROME
by: Armstrong, R, et al.
Published: (1994)

Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
by: Winchester, LM, et al.
Published: (2023)

Education and prevalence of Alzheimer's disease and vascular dementia. Premorbid ability influences measures used to identify dementia.
by: O'Carroll, R, et al.
Published: (1995)

Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.
by: Barker, R, et al.
Published: (2014)

Senile chorea treated by deep brain stimulation: a clinical, neurophysiological and functional imaging study.
by: Yianni, J, et al.
Published: (2004)

The metabolic syndrome and Alzheimer disease.
by: Razay, G, et al.
Published: (2007)

Aids for people with alzheimer’s disease or other dementia II
by: Mok, Wei Jie.
Published: (2013)

Aids for people with Alzheimer's disease or other dementia I
by: Ang, Yu Kun
Published: (2013)

Defying dementia : understanding and preventing Alzheimers and related disorders /
by: Levine, Robert, 1939-
Published: (2006)

Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study.
by: Razay, G, et al.
Published: (2009)

Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
by: McShane, R, et al.
Published: (2001)

“Senility and death of tissues are not a necessary phenomenon” : Alexis Carrel and the origins of gerontology
by: Park, Hyung Wook
Published: (2013)

New insights into the genetic etiology of Alzheimer’s disease and related dementias
by: Bellenguez, C, et al.
Published: (2022)

Multi-omic Analysis of Neurodegeneration in Alzheimer’s Disease and Related Dementias
by: Howe, Stephanie Pui-kay
Published: (2024)